BullFrog AI Holdings, Inc. Logo

BullFrog AI Holdings, Inc.

Leverages causal AI to accelerate drug discovery and identify novel targets for biopharmaceuticals.

BFRG | US

Overview

Corporate Details

ISIN(s):
US12021E1091
LEI:
Country:
United States of America
Address:
325 ELLINGTON BLVD., 20878 GAITHERSBURG
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BullFrog AI Holdings, Inc. is a technology-enabled biopharmaceutical company that leverages artificial intelligence (AI) and machine learning (ML) to enhance the drug discovery and development process. The company utilizes a proprietary platform featuring causal AI and graph-based analytics to model complex biological systems. This technology enables the rapid and cost-effective identification and validation of novel drug targets, aiming to generate actionable insights from complex data. By supporting both internal and external drug development programs, BullFrog AI's mission is to accelerate research, lower costs, and significantly improve the success rate of bringing new therapeutics to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BullFrog AI Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BullFrog AI Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BullFrog AI Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Metagenomi, Inc. Logo
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America
MGX
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Mips Logo
Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.
Sweden
MIPS
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC
Monopar Therapeutics Logo
Clinical-stage biotech developing radiopharmaceuticals for oncology and therapies for rare diseases.
United States of America
MNPR
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland
MURA
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom
N4P
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland
NNG

Talk to a Data Expert

Have a question? We'll get back to you promptly.